GLS and malignant colon neoplasm: For example, the m6A reader YTHDF1 promotes GLS expression in colon cancer, contributing to cisplatin resistance, while IGF2BP3 enhances glutamine and glutamic acid metabolism in cervical cancer cells by upregulating GLS expression, thereby facilitating immune evasion59, 60.